Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy – the influence of the choice of the reference region and conversion function
暂无分享,去创建一个
P. Lambin | A. Even | I. Toma-Dasu | P. Wersäll | A. Dasu | E. Lindblom | J. Uhrdin | W. van Elmpt
[1] P. Lambin,et al. Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[2] Philippe Lambin,et al. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] P. Lambin,et al. Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma , 2015, Acta oncologica.
[4] W. V. van Elmpt,et al. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia – a simulation study , 2015, Acta oncologica.
[5] P. Lambin,et al. Repeatability of hypoxia PET imaging using [18F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[6] A. Windhorst,et al. Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Kenneth A Krohn,et al. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. , 2015, Seminars in nuclear medicine.
[8] P. Lambin,et al. A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model. , 2015, International journal of radiation oncology, biology, physics.
[9] P. Lambin,et al. In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging , 2014, Clinical Cancer Research.
[10] Hanwen Zhang,et al. A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers , 2014, The Journal of Nuclear Medicine.
[11] V. Khoo,et al. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using 18F-FMISO PET: A biological modeling study , 2013, Acta oncologica.
[12] P. Lambin,et al. Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] Yihui Guan,et al. 18F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with 18F-FMISO , 2012, Nuclear medicine communications.
[14] Anders Brahme,et al. Dose prescription and treatment planning based on FMISO-PET hypoxia , 2012, Acta oncologica.
[15] Philippe Lambin,et al. Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging , 2011, Proceedings of the National Academy of Sciences.
[16] Vincent Gregoire,et al. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.
[17] M. Dewhirst,et al. Molecular Imaging of Hypoxia , 2011, The Journal of Nuclear Medicine.
[18] Philippe Lambin,et al. PET imaging of hypoxia using [18F]HX4: a phase I trial , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[19] Matthias Reimold,et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[21] S. Dische. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] J. D. Chapman,et al. A marker for hypoxic cells in tumours with potential clinical applicability. , 1981, British Journal of Cancer.
[23] Chapman Jd,et al. Hypoxic sensitizers--implications for radiation therapy. , 1979 .
[24] P. Lambin,et al. A Comparative Study of the Hypoxia PET Tracers ( 18 F)HX4, ( 18 F)FAZA, and ( 18 F)FMISO in a , 2015 .
[25] Anders Brahme,et al. Quantifying tumour hypoxia by PET imaging--a theoretical analysis. , 2009, Advances in experimental medicine and biology.
[26] K L Lindsley,et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.
[27] J. Chapman. Hypoxic sensitizers--implications for radiation therapy. , 1979, The New England journal of medicine.